$19.59
Insights on Envista Holdings
Revenue is up for the last 2 quarters, 631.3M → 645.6M (in $), with an average increase of 2.2% per quarter
Netprofit is down for the last 3 quarters, 51.9M → -217.4M (in $), with an average decrease of 584.9% per quarter
In the last 1 year, Intuitive Surgical, Inc. has given 39.0% return, outperforming this stock by 86.4%
In the last 3 years, Intuitive Surgical, Inc. has given 38.1% return, outperforming this stock by 92.0%
0.48%
Downside
Day's Volatility :2.33%
Upside
1.85%
3.27%
Downside
52 Weeks Volatility :51.76%
Upside
50.13%
Period | Envista Holdings | Sector (Health Care) | Index (Russel 2000) |
---|---|---|---|
3 Months | -18.58% | -0.7% | 0.0% |
6 Months | -21.26% | 6.6% | 0.0% |
1 Year | -47.4% | 3.7% | -1.5% |
3 Years | -54.09% | 14.0% | -21.8% |
Market Capitalization | 3.4B |
Book Value | $24.34 |
Earnings Per Share (EPS) | -0.6 |
Wall Street Target Price | 23.8 |
Profit Margin | -3.9% |
Operating Margin TTM | 10.6% |
Return On Assets TTM | 3.1% |
Return On Equity TTM | -2.39% |
Revenue TTM | 2.6B |
Revenue Per Share TTM | 15.38 |
Quarterly Revenue Growth YOY | -2.3% |
Gross Profit TTM | 1.5B |
EBITDA | 463.0M |
Diluted Eps TTM | -0.6 |
Quarterly Earnings Growth YOY | -0.55 |
EPS Estimate Current Year | 1.42 |
EPS Estimate Next Year | 1.61 |
EPS Estimate Current Quarter | 0.34 |
EPS Estimate Next Quarter | 0.37 |
What analysts predicted
Upside of 21.49%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 2.8B | ↑ 1.2% |
Net Income | 230.7M | ↓ 23.38% |
Net Profit Margin | 8.11% | ↓ 2.6% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 2.8B | ↓ 3.27% |
Net Income | 217.6M | ↓ 5.68% |
Net Profit Margin | 7.91% | ↓ 0.2% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 2.3B | ↓ 17.07% |
Net Income | 33.3M | ↓ 84.7% |
Net Profit Margin | 1.46% | ↓ 6.45% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 2.5B | ↑ 9.94% |
Net Income | 263.5M | ↑ 691.29% |
Net Profit Margin | 10.5% | ↑ 9.04% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 2.6B | ↑ 2.4% |
Net Income | 243.1M | ↓ 7.74% |
Net Profit Margin | 9.46% | ↓ 1.04% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 3.7B | ↑ 43.73% |
Net Income | -100.2M | ↓ 141.22% |
Net Profit Margin | -2.71% | ↓ 12.17% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Revenue | 631.1M | ↓ 2.28% |
Net Income | 47.6M | ↑ 1.06% |
Net Profit Margin | 7.54% | ↑ 0.25% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 660.8M | ↑ 4.71% |
Net Income | 73.5M | ↑ 54.41% |
Net Profit Margin | 11.12% | ↑ 3.58% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 627.2M | ↓ 5.08% |
Net Income | 43.8M | ↓ 40.41% |
Net Profit Margin | 6.98% | ↓ 4.14% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 662.4M | ↑ 5.61% |
Net Income | 51.9M | ↑ 18.49% |
Net Profit Margin | 7.84% | ↑ 0.86% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 631.3M | ↓ 4.7% |
Net Income | 21.5M | ↓ 58.57% |
Net Profit Margin | 3.41% | ↓ 4.43% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 645.6M | ↑ 2.27% |
Net Income | -217.4M | ↓ 1111.16% |
Net Profit Margin | -33.67% | ↓ 37.08% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 5.8B | ↓ 2.52% |
Total Liabilities | 1.0B | ↑ 1.7% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 6.2B | ↑ 5.42% |
Total Liabilities | 2.6B | ↑ 157.63% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 6.9B | ↑ 11.65% |
Total Liabilities | 3.2B | ↑ 20.63% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 6.6B | ↓ 4.39% |
Total Liabilities | 2.5B | ↓ 20.25% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 6.6B | ↑ 0.19% |
Total Liabilities | 2.4B | ↓ 5.41% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 6.6B | ↑ 0.27% |
Total Liabilities | 2.4B | ↑ 2.15% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 6.4B | ↓ 0.76% |
Total Liabilities | 2.5B | ↑ 0.37% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 6.6B | ↑ 2.73% |
Total Liabilities | 2.4B | ↓ 3.01% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 6.6B | ↓ 0.18% |
Total Liabilities | 2.3B | ↓ 3.53% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 6.6B | ↑ 0.49% |
Total Liabilities | 2.3B | ↑ 0.01% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 6.7B | ↑ 1.16% |
Total Liabilities | 2.4B | ↑ 4.11% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 6.6B | ↓ 1.18% |
Total Liabilities | 2.4B | ↑ 1.7% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 400.1M | ↑ 11.42% |
Investing Cash Flow | -75.5M | ↑ 37.52% |
Financing Cash Flow | -324.6M | ↑ 6.71% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 397.5M | ↓ 0.65% |
Investing Cash Flow | -78.4M | ↑ 3.84% |
Financing Cash Flow | -107.7M | ↓ 66.82% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 283.9M | ↓ 28.58% |
Investing Cash Flow | -69.1M | ↓ 11.86% |
Financing Cash Flow | 492.5M | ↓ 557.29% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 391.4M | ↑ 37.87% |
Investing Cash Flow | 232.9M | ↓ 437.05% |
Financing Cash Flow | -465.6M | ↓ 194.54% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 182.7M | ↓ 53.32% |
Investing Cash Flow | -657.3M | ↓ 382.22% |
Financing Cash Flow | 12.5M | ↓ 102.68% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 46.7M | ↑ 110.36% |
Investing Cash Flow | -69.7M | ↓ 88.22% |
Financing Cash Flow | 73.7M | ↑ 3994.44% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 110.3M | ↑ 136.19% |
Investing Cash Flow | -1.1M | ↓ 98.42% |
Financing Cash Flow | -68.3M | ↓ 192.67% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 3.1M | ↓ 97.19% |
Investing Cash Flow | -22.0M | ↑ 1900.0% |
Financing Cash Flow | -1.5M | ↓ 97.8% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 75.1M | ↑ 2322.58% |
Investing Cash Flow | -2.8M | ↓ 87.27% |
Financing Cash Flow | 2.6M | ↓ 273.33% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 95.5M | ↑ 27.16% |
Investing Cash Flow | -25.0M | ↑ 792.86% |
Financing Cash Flow | 114.5M | ↑ 4303.85% |
Sell
Neutral
Buy
Envista Holdings is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Envista Holdings | -8.59% | -21.26% | -47.4% | -54.09% | -29.91% |
Intuitive Surgical, Inc. | -4.7% | 35.81% | 38.95% | 38.38% | 112.57% |
Resmed Inc. | -8.97% | 22.05% | -22.01% | -15.48% | 75.2% |
Becton, Dickinson And Company | -2.32% | -10.48% | -8.43% | -10.33% | 1.9% |
West Pharmaceutical Services Inc | -4.64% | 0.62% | 4.23% | 19.12% | 238.38% |
Alcon Ag | -6.1% | 7.94% | 11.1% | 7.08% | 42.78% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Envista Holdings | 22.44 | NA | NA | 1.42 | -0.02 | 0.03 | NA | 24.34 |
Intuitive Surgical, Inc. | 75.26 | 75.26 | 7.13 | 6.25 | 0.15 | 0.08 | NA | 37.77 |
Resmed Inc. | 30.61 | 30.61 | 1.75 | 7.41 | 0.22 | 0.11 | 0.01 | 30.47 |
Becton, Dickinson And Company | 52.86 | 52.86 | 1.34 | 12.95 | 0.05 | 0.03 | 0.02 | 87.68 |
West Pharmaceutical Services Inc | 48.1 | 48.1 | 6.72 | 7.62 | 0.21 | 0.12 | 0.0 | 39.2 |
Alcon Ag | 40.62 | 40.62 | 4.59 | 3.06 | 0.05 | 0.02 | 0.0 | 41.81 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Envista Holdings | Buy | $3.4B | -29.91% | 22.44 | -3.9% |
Intuitive Surgical, Inc. | Buy | $134.2B | 112.57% | 75.26 | 25.24% |
Resmed Inc. | Buy | $27.2B | 75.2% | 30.61 | 19.77% |
Becton, Dickinson And Company | Buy | $67.8B | 1.9% | 52.86 | 6.44% |
West Pharmaceutical Services Inc | Buy | $27.8B | 238.38% | 48.1 | 20.12% |
Alcon Ag | Buy | $39.5B | 42.78% | 40.62 | 10.3% |
BlackRock Inc
Vanguard Group Inc
Morgan Stanley - Brokerage Accounts
Harris Associates L.P.
Ariel Investments, LLC
Dimensional Fund Advisors, Inc.
we know that dental professionals do more than create healthy, beautiful smiles—they create confidence. to achieve their goals, they need a champion. they need someone who will be there for them, side by side and end to end. at envista, we are uniquely positioned to be this champion. our differentiated combination of continuous improvement, a bias toward action and innovation, and a deep respect for the professionals we serve embolden us to champion dental professionals like no one else can. our comprehensive product portfolio covers an estimated 90% of dentists’ clinical needs for diagnosing, treating and preventing dental conditions as well as improving the aesthetics of the human smile. we believe true champions lift each other up, and we are looking for new champions to join our team. if you believe, champions do more than win, they stand for something bigger, you can build a meaningful career at envista. if you believe champions work to be their best, help others be theirs, sho
Organization | Envista Holdings |
Employees | 12800 |
CEO | Mr. Amir Aghdaei |
Industry | Health Technology |
Vanguard Ultra Short Bond Et
$19.59
-0.96%
Surgery Partners Inc
$19.59
-0.96%
Sl Green Realty Corp.
$19.59
-0.96%
Goldman Sachs Activebeta Int
$19.59
-0.96%
Allegro Microsystems, Inc.
$19.59
-0.96%
Cleanspark Inc
$19.59
-0.96%
Chart Industries Inc.
$19.59
-0.96%
Agree Realty Corp
$19.59
-0.96%
Joby Aviation Inc
$19.59
-0.96%